U.S. Electronic Equipment and Components Stock News

NasdaqGS:RBCA.A
NasdaqGS:RBCA.ABanks

Republic Bancorp Joins S&P Index With Apparent Valuation Upside

Republic Bancorp, Inc. (NasdaqGS:RBCA.A) has been added to the S&P Regional Banks Select Industry Index. The inclusion places the company alongside a peer group of publicly traded regional banks tracked by institutional and index investors. Republic Bancorp operates as a regional banking company, with its core business centered on traditional lending, deposits, and related financial services. Inclusion in the S&P Regional Banks Select Industry Index can draw more attention from...
NasdaqGM:BZAI
NasdaqGM:BZAISemiconductor

A Look At Blaize Holdings (BZAI) Valuation As Earnings Guidance And Going Concern Warning Draw Focus

Why Blaize Holdings is in the spotlight Blaize Holdings (BZAI) has drawn fresh attention after releasing fourth quarter and full year 2025 results, issuing 2026 revenue guidance, and receiving an auditor warning about its ability to continue as a going concern. See our latest analysis for Blaize Holdings. The latest earnings release, 2026 revenue guidance and the auditor’s going concern warning have coincided with sharp swings in sentiment. A 62.04% 7 day share price return and a 37.05%...
NasdaqGS:CGNT
NasdaqGS:CGNTSoftware

Cognyte Software (CGNT) Turns Q4 Profit Of US$3.8m Challenging Persistent Loss Narrative

Cognyte Software (CGNT) has wrapped up FY 2026 with fourth quarter revenue of US$106.2 million and basic EPS of US$0.05, alongside net income excluding extra items of US$3.8 million. Over recent periods, the company has seen quarterly revenue move from US$89.0 million in FY 2025 Q3 to US$106.2 million in FY 2026 Q4, while basic EPS has ranged between a loss of US$0.07 and a profit of US$0.05 across the same stretch. For investors, the key point is how these top line gains and shifting EPS...
NasdaqGS:APLS
NasdaqGS:APLSBiotechs

Is It Time To Reconsider Apellis Pharmaceuticals (APLS) After Its Recent Share Price Slump?

If you are wondering whether Apellis Pharmaceuticals at US$17.64 is starting to look interesting on price alone, this article walks through what that tag might really represent for you as a shareholder or potential buyer. The stock has recently been under pressure, with returns of a 1.8% decline over 7 days, 20.3% decline over 30 days, 31.8% decline year to date, and 27.3% decline over the past year, which can change how the market views both risk and potential reward. Recent company...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Bio Techne Spatial Biology Expansion And What It Could Mean For Valuation

Bio-Techne, ticker NasdaqGS:TECH, has expanded its COMET spatial biology workflow with new SPYRE Focus Panels and Amplification Kits. The company has also released upgrades to its HORIZON Image Analysis Software to support more advanced tissue analysis. The updates aim to give researchers greater flexibility, sensitivity, and throughput in preclinical and translational studies. Bio-Techne is adding this product expansion at a time when the share price is around $52.70, with the stock down...
NasdaqGS:ADEA
NasdaqGS:ADEASoftware

Is It Too Late To Consider Adeia (ADEA) After Its 77% One Year Rally?

If you are wondering whether Adeia's share price still reflects fair value after its recent run, this breakdown will help you separate price from worth. The stock last closed at US$24.36, with returns of 3.9% over 7 days, 23.3% over 30 days, 38.6% year to date and 76.7% over the past year, providing context for any valuation check. Recent coverage has focused on Adeia's role as a software company and the way investors are reacting to its business model and positioning. This backdrop helps...
NasdaqGS:IREN
NasdaqGS:IRENSoftware

IREN Flags AI Data Center Constraints As Valuation And Risks Diverge

IREN (NasdaqGS:IREN) CEO recently flagged permanent and escalating challenges in building global AI infrastructure. The CEO said that even with chip supply and energy in place, bottlenecks remain due to the physical constraints of deploying AI data centers. The comments highlight that the race to expand AI capacity is constrained by real world buildout limits, not just technology or software. For you as an investor, the message is that AI growth is not only a story about GPUs and power...
NYSE:PAG
NYSE:PAGSpecialty Retail

Penske Sale Of Lexus Of Warwick Signals Ongoing Portfolio Reset

Penske Automotive Group (NYSE:PAG) has completed the sale of Lexus of Warwick in Rhode Island. The buyer is the McGee Automotive Family, which plans to continue operating the dealership as a Lexus store. The transaction marks a change in Penske Automotive Group's dealer portfolio and geographic mix. Penske Automotive Group (NYSE:PAG) is a diversified transportation services company with a large network of franchised dealerships. The sale of Lexus of Warwick fits into a broader pattern of...
NYSE:RHI
NYSE:RHIProfessional Services

Fortune Recognition Puts Robert Half AI Focus And Valuation In Spotlight

Robert Half (NYSE:RHI) has been recognized by Fortune as one of America's Most Innovative Companies 2026. The award highlights the firm's work with AI powered tools and technology driven solutions across its business. This external recognition may influence how clients and investors view Robert Half's brand and competitive position. For investors watching NYSE:RHI, this recognition comes with the shares trading at $25.09. The stock has seen a 9.3% return over the past week and 6.3% over the...
NasdaqCM:WYFI
NasdaqCM:WYFIIT

WhiteFiber (WYFI) Q3 Loss Of US$15.8 Million Tests Bullish Profitability Narrative

WhiteFiber (NasdaqCM:WYFI) has posted its FY 2025 results with Q3 revenue of about US$20.2 million and a basic EPS loss of US$0.47, set against trailing twelve month revenue of roughly US$70.2 million and a net loss of US$24.2 million. Over the past several quarters, the company has seen revenue move from US$12.3 million in Q3 FY 2024 to US$20.2 million in Q3 FY 2025, while quarterly net income has swung between a profit of US$1.4 million in Q1 FY 2025 and a loss of US$15.8 million in Q3 FY...
NasdaqGS:MGTX
NasdaqGS:MGTXBiotechs

MeiraGTx Holdings (MGTX) Q3 Loss Of US$50.5m Reinforces Bearish Community Narratives

MeiraGTx Holdings (MGTX) just posted its FY 2025 third quarter numbers, with revenue at US$0.4 million and a basic EPS loss of US$0.62, alongside net income excluding extra items of a US$50.5 million loss. Over recent quarters, the company has seen revenue move from US$21.4 million in Q4 2024 to US$3.7 million in Q2 2025, while quarterly basic EPS has tracked between a loss of US$0.48 and US$0.76. This sets the backdrop for the current trailing twelve month loss of US$168.7 million on US$27.4...
NasdaqGM:FIVN
NasdaqGM:FIVNSoftware

Is It Time To Reconsider Five9 (FIVN) After Its Steep Multi‑Year Share Price Slide

If you are wondering whether Five9's current share price still reflects its potential, the recent valuation picture gives you clear numbers to work with. The stock closed at US$15.12, with returns of a 4.3% decline over 7 days, a 15.2% decline over 30 days, a 19.6% decline year to date, a 48.4% decline over 1 year, a 77.9% decline over 3 years, and a 90.8% decline over 5 years, which may change how you think about its risk and return profile. Recent coverage has focused on how Five9 fits...
NasdaqCM:HIT
NasdaqCM:HITInsurance

Health In Tech (HIT) Margin Compression Tests Bullish Narratives Despite 55.1% Revenue Growth

Health In Tech (HIT) has put up another busy quarter in FY 2025, with Q3 revenue of about US$8.5 million and basic EPS of US$0.008, set against a year where revenue was 55.1% higher and trailing net profit margins sat at 4.7% compared with 9.2% a year earlier. Over recent periods the company has seen quarterly revenue move from about US$5.0 million in Q2 2024 to US$4.9 million in Q4 2024, then to US$8.0 million in Q1 2025, US$9.3 million in Q2 2025 and US$8.5 million in Q3 2025. Over the same...
NasdaqGS:PONY
NasdaqGS:PONYSoftware

Pony AI (PONY) Q3 Loss Of US$61 Million Tests High Growth Bullish Narratives

Pony AI (PONY) just posted its FY 2025 third quarter numbers, with revenue at US$25.4 million and a basic EPS loss of US$0.16, while trailing twelve month figures show revenue of US$96.4 million and a basic EPS loss of US$1.05. Over recent quarters the company has seen revenue move from US$12.2 million in Q2 2024 to US$14.8 million in Q3 2024 and then to US$13.0 million, US$21.5 million and US$25.4 million in Q1, Q2 and Q3 2025 respectively, alongside quarterly basic EPS losses of US$0.33,...
OTCPK:UTGN
OTCPK:UTGNInsurance

United Guardian (OTCPK:UTGN) Q4 Loss And Margin Compression Challenge Bullish Narratives

United Guardian (OTCPK:UTGN) has wrapped up FY 2025 with a mixed set of numbers, as Q4 revenue came in at a slight loss of US$0.3 million and net income swung to a loss of US$4.2 million, against a backdrop where trailing 12 month revenue sits at US$42.3 million and net income at US$17.1 million. Over recent quarters the company has seen revenue move from US$16.2 million and EPS of US$2.33 in Q4 2024 to US$21.9 million and EPS of US$4.05 in Q1 2025, before settling at US$17.3 million and EPS...
NYSE:CMC
NYSE:CMCMetals and Mining

Commercial Metals (CMC) Margin Rebound Challenges Bearish Earnings Narratives

Commercial Metals (CMC) has just turned in its Q2 2026 scorecard, with Q1 2026 revenue of US$2.1 billion and net income of US$177.3 million translating into EPS of US$1.60, while trailing twelve month figures show revenue of US$8.0 billion, net income of US$437.7 million and EPS of US$3.90. Investors have seen revenue move from US$1.8 billion in Q2 2025 to US$2.1 billion in Q1 2026, as EPS swung from US$0.22 to US$1.60 over the same stretch. This sets up a quarter where higher earnings are...
NYSE:MWA
NYSE:MWAMachinery

Mueller Water Director Purchase Underscores Confidence In Free Cash Flow Story

Mueller Water Products director Gregg C. Sengstack recently increased his personal stake through an open-market share purchase. The insider transaction signals clear internal commitment to the company’s direction and outlook. The move comes as investors are watching insider activity at NYSE:MWA for additional clues about management’s confidence. Mueller Water Products, ticker NYSE:MWA, is drawing fresh attention after this insider purchase, with the stock most recently closing at $27.8. The...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Precigen (PGEN) Quarterly Loss Swings Challenge Bullish Growth Narrative After FY 2025 Results

Precigen (PGEN) has just closed out FY 2025 with fourth quarter revenue of US$4.6 million, a basic EPS loss of US$0.07, and net income loss of US$23.5 million. Over the past year, the company has seen revenue move from US$1.2 million in Q4 2024 to US$4.6 million in Q4 2025. Trailing twelve month basic EPS sits at a loss of US$1.37 and net income loss over the same period totals US$429.6 million, which keeps the spotlight firmly on how quickly margins can improve from here. See our full...
NasdaqGS:OLED
NasdaqGS:OLEDSemiconductor

Universal Display Uses ICDT 2026 Stage To Reinforce PHOLED Investment Story

Universal Display (NasdaqGS:OLED) is set to be in the spotlight at ICDT 2026 as a technical sponsor of the conference. The company is highlighting new OLED materials technology, with a focus on advances in emissive layer design. A principal technologist from Universal Display is giving an invited talk on PHOLED materials, underscoring their role in next generation display architectures. Universal Display, known for its OLED materials and licensing business, is positioned within long running...
OTCPK:MGTE
OTCPK:MGTEDiversified Financial

Marblegate Capital (OTCPK:MGTE) Revenue Decline Of 35.8% Tests Bullish Recovery Narratives

Marblegate Capital (OTCPK:MGTE) has just posted its FY 2025 numbers, reporting Q3 revenue of US$12.0 million and a basic EPS loss of US$0.02. This is set against a trailing 12 month revenue base of US$10.3 million and a basic EPS loss of US$0.91 that reflects the broader year. Over recent quarters, the company’s revenue has moved from US$5.1 million in Q2 2024 to US$5.4 million in Q3 2024 and then to US$4.6 million, US$9.7 million and US$12.0 million in Q1, Q2 and Q3 2025 respectively. EPS...
NYSE:XYF
NYSE:XYFConsumer Finance

X Financial (NYSE:XYF) One Off CN¥3.2b Loss Tests Bullish Earnings Narrative

X Financial (NYSE:XYF) has put solid numbers on the board for FY 2025 so far, with Q3 revenue of CN¥1,960.9 million and basic EPS of CN¥10.58, while trailing 12 month figures sit at CN¥7.9 billion of revenue and basic EPS of CN¥42.07, underpinned by net income of CN¥1,793.0 million. Over recent reporting periods the company has seen revenue move from CN¥1,372.6 million in Q2 2024 to CN¥2,273.1 million in Q2 2025. Quarterly basic EPS shifted from CN¥8.48 to CN¥12.59, setting up a results...
NYSE:KRMN
NYSE:KRMNAerospace & Defense

Karman Holdings (KRMN) Q4 Revenue Growth Tests Bullish Margin Expansion Narrative

Karman Holdings (KRMN) has just wrapped up FY 2025 with fourth quarter revenue of US$134.5 million and net income of US$7.7 million, translating to basic EPS of US$0.06. Over the past six quarters, the company has seen revenue move from US$86.0 million in Q3 2024 to US$134.5 million in Q4 2025, while quarterly EPS shifted from US$0.03 to roughly US$0.06, against a backdrop of trailing twelve month EPS of US$0.13 and net income of US$17.4 million. With net profit margins sitting at 3.7% and...
NasdaqCM:DERM
NasdaqCM:DERMPharmaceuticals

Journey Medical (DERM) Losses Narrow In Q4 EPS Result Tests Bullish Profitability Narrative

Journey Medical (DERM) closed FY 2025 with Q4 revenue of US$16.1 million and a basic EPS loss of US$0.05, while trailing twelve month figures show revenue of US$61.9 million and a basic EPS loss of US$0.47. Over recent quarters, revenue has ranged from US$13.1 million in Q1 2025 to US$17.6 million in Q3 2025, with basic EPS moving between a loss of US$0.18 and a loss of US$0.05. This sets up a story in which top line scale is building while margins remain under pressure. See our full analysis...
NasdaqCM:FXNC
NasdaqCM:FXNCBanks

First National (FXNC) Net Interest Margin Strengthens Bullish Narratives In FY 2025 Earnings

First National (FXNC) has reported FY 2025 results with fourth quarter revenue of US$23.0 million and EPS of US$0.61, capping a trailing twelve month revenue line of US$87.0 million and EPS of US$1.97 that reflects 154.1% earnings growth over the past year. Over recent periods, revenue has moved from US$13.3 million in Q3 2024 to US$17.1 million in Q4 2024 and then to US$23.0 million in Q4 2025. Quarterly EPS shifted from a loss of US$0.10 in Q4 2024 to US$0.61 in Q4 2025, highlighting a...